Transvaginal mesh implant for pelvic organ prolapse: Huaxi protocol

With increasing age, pelvic organ prolapse(POP), due to its high incidence,has become a common disease that seriously affects patients' quality of life and places a heavy economic burden on families and society. Transvaginal mesh(TVM) is a minimally invasive and effective treatment for POP,although its use remains controversial due to the potential risk of meshrelated complications. The US Foods and Drugs Administration, along with authorities in England, Australia, New Zealand, and other countries, have banned the sale and distribution of commercial TVM kits designed for POP.The TVM procedure remains an option for POP treatment and still appeals to many surgeons and patients today in Asia and most European countries,which suggests that a considerable number of POP patients can benefit from its continued refinement. Here we introduce the Huaxi protocol of the TVM plant for the treatment of POP.